| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Murphy Matthew B. is a General Counsel at NAUT. Recent filings cover 4 purchases and 0 sales. Those positions are worth an estimated $48K at current prices.
Our model assigns Murphy Matthew B. a below-average insider score of 45/100, based on 4 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -15.6%.
Murphy Matthew B.'s largest disclosed position is in NAUT as General Counsel, worth about $48K. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | NAUT Nautilus Biotechnology, Inc. | General Counsel | Buy | 20,000 | $0.64 | $12,858.00 | +36.9% | +219.1% | +38.8% | |
| Aug 15, 2022 | NAUT Nautilus Biotechnology, Inc. | General Counsel | Buy | 10,000 | $2.84 | $28,432.50 | +22.7% | -29.8% | +9.6% | |
| Aug 13, 2021 | NAUT Nautilus Biotechnology, Inc. | General Counsel | Buy | 5,000 | $7.56 | $37,806.50 | +17.2% | -31.9% | -62.2% |